Gilead Sciences

Senior Scientist, Medicinal and Structural Chemistry

Foster City, California, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical Research, Drug DiscoveryIndustries

Requirements

Candidates must possess a Ph.D. in a relevant field, with a minimum of 5 years of experience, or a Master’s degree with 10 years of experience, and a deep understanding of both medicinal chemistry and NMR spectroscopy as applied to small molecule drug discovery. Strong expertise in hit to lead approaches, including library expansion and parallel chemistry is highly valued.

Responsibilities

The Senior Scientist will be responsible for further developing the strategy for NMR spectroscopy, maintaining the NMR facility to ensure optimal performance, obtaining and interpreting multidimensional NMR data, providing detailed reports and insights on chemical structures and properties, developing and optimizing NMR methods, maintaining accurate records of experiments and analyses, providing training and technical support, and collaborating effectively with cross-functional teams.

Skills

NMR Spectroscopy

Medicinal Chemistry

Hit to Lead

Library Expansion

Parallel Chemistry

NMR Methods

Data Interpretation

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free